SS
CGTX icon

SBI Securities’s Cognition Therapeutics CGTX Stock Holding History

SBI Securities’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58 Buy
50
+34
+213% +$40 ﹤0.01% 3636
2026
Q1 		$12 Buy
16
+11
+220% +$13 ﹤0.01% 3826
2025
Q4 		$7 Buy
5
+4
+400% +$6 ﹤0.01% 3900
2025
Q3 		$1 Sell
1
-400
-100% -$545 ﹤0.01% 4165
2025
Q2 		$124 Hold
401
– – ﹤0.01% 3469
2025
Q1 		$169 Buy
+401
New +$236 ﹤0.01% 3276

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

SBI Securities's CGTX Position: Q2 2026 in Review

SBI Securities increased its Cognition Therapeutics (CGTX) stake by 213% in Q2 2026, buying an estimated $40 and bringing the position to 50 shares worth $58. The position accounts for ﹤0.01% of the portfolio, ranked #3636.

SBI Securities first reported a position in CGTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $169 in Q1 2025. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • SBI Securities held 50 shares of Cognition Therapeutics worth $58 as of Q2 2026.
  • SBI Securities bought 34 Cognition Therapeutics shares in Q2 2026, an estimated $40.
  • Cognition Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3636 holding.
  • SBI Securities first reported a position in Cognition Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • SBI Securities's Cognition Therapeutics position peaked at $169 in Q1 2025.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.